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Abstract
Objective Anxiety is the most frequent emotional
reaction to the chronic somatic disease. However, little
is known about anxiety and coping strategies in
patients with end-stage renal disease (ESRD) under-
going renal replacement therapies (RRTs). The pur-
pose of the study was to assess the intensity and
determinants of anxiety in patients treated with
different RRTs in comparison with end-stage breast
cancer patients and healthy controls.
Methods The study involved (1) ESRD patients
undergoing different RRTs: 32 renal transplant recip-
ients, 31 maintenance haemodialysis and 21 chronic
peritoneal dialysis patients, (2) women with end-stage
breast cancer (n = 25) and (3) healthy persons
(n = 55). We used State–Trait Anxiety Inventory,
Scale of Personal Religiousness, Mental Adjustment
to Cancer Scale, Rotterdam Symptom Checklist with
reference to medical history. The data thus obtained
were analysed using the analysis of variance, the
Tukey’s HSD post hoc test and Spearman’s rank
correlation coefficient.
Results Both ESRD and breast cancer patients
revealed higher level of anxiety state and trait than
healthy controls; however, there was no statistically
significant difference found between both findings.
There was a tendency towards higher levels of anxiety
state in breast cancer patients when compared to
ESRD patients undergoing the RRT treatment and for
both groups non-constructive coping strategies corre-
lated with the levels of anxiety state. With ESRD
patients undergoing RRTs, the intensity of anxiety
state did not depend on the mode of treatment but on
the correlation between the levels of anxiety and the
general quality of their life, psychological condition
and social activity.
Conclusion In patients with advanced somatic dis-
ease (ESRD and end-stage breast cancer), non-
constructive strategies of coping with the disease
require further evaluation and possibly psychological
support.
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Kt/V Urea clearance over dialysis time/
volume of distribution of urea
Mini-MAC The Mini-Mental Adjustment to Cancer
Scale
p Coefficient of statistical significance
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r The Spearman’s rank correlation
coefficient
RRT Renal replacement therapy
RSCL The Rotterdam Symptom Checklist
RTx Renal transplant patients
SPR The Scale of Personal Religiousness
STAI The State–Trait Anxiety Inventory
QoL Quality of life
Introduction
End-stage renal disease (ESRD) has become a major
increasingly prevalent health issue. Patients’ perma-
nent loss of renal function requiring a chronic renal
replacement therapy (RRT) leads to dramatic life
changes. RRTs prolong the lives of ESRD patients but
at the same time bring them an enormous burden. A
broad range of physical symptoms, activity limita-
tions, altered body image, fatigue and various treat-
ment-related restrictions are stressors precipitating the
need for coping efforts and possibly leading to
negative outcomes such as depression and anxiety.
Therefore, psychological disorders are frequently
encountered in such cases [1, 2].
Anxiety is an unpleasant emotion affecting patients
with advanced somatic disease, and there are various
ways of coping with it. Most scientists who deal with
the issue of emotional reactions to somatic disease
point out that it is anxiety which is the most common
emotional response to somatic diseases [3–6]. Anxiety
is a response to either a threatening situation, a risk of
losing an important value or a lack of stability, that is,
the feeling of insecurity connected with finding
oneself in a new unfamiliar situation [5]. We can
assess anxiety as a fairly stable anxiety-related trait
combined with personality features and a variable
anxiety-induced state, which depends on external
factors. Getting ill involves the risk of a patient’s
permanent loss of health, development of disability or
even death. At the same time, the disease changes the
level of one’s self-esteem and one’s previous ways of
dealing with problems. Thus, the phenomenon of
anxiety occurs at the very onset of disease symptoms
during diagnostic and treatment stages, which follow,
especially if hospitalization is necessary [5].
It has been frequently observed that there is a clear
association between the patient’s religiousness and
spirituality, on the one hand, and clinical outcomes on
the other. One’s spirituality and religious involvement
may play the key role in developing coping mecha-
nisms, which—as has been verified—both improve
one’s quality of life (QoL) and reduce one’s percep-
tion of the burden of illness and of its depressive
effects [7, 8]. Spinale et al. [9] showed that highly
developed spirituality resulted in patients’ improved
chances of survival with regard to the haemodialysis
population, but religion as a coping mechanism did
not. In end-stage cancer patients, religiousness turned
out to be an effective tool for coping with anxiety.
Because little is known about anxiety and the coping
strategies in patients undergoing renal replacement
therapies, it is also not known if religiousness is a
determinant of anxiety in ESRD population.
Objectives
The detailed aims of the study were
(a) To establish the intensity of anxiety trait and
anxiety state in study groups.
(b) To find the relationship between physical symp-
toms, psychological symptoms, social activity
and general quality of life and level of anxiety
patients undergoing different RRTs (haemodial-
ysis, peritoneal dialysis, renal transplant recipi-
ents) and cancer patients.
(c) To assess the association between anxiety state
and coping strategies in patients.
(d) To find out if religiousness has an impact on
anxiety levels in the studied groups.
Materials and methods
The study involved 164 subjects (85 women and 79
men), aged between 22 and 80 (average age: 49.17)
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who comprised three study groups: the first group
(I) consisted of patients undergoing different modes of
RRT (n = 84) divided into three groups according to
method of treatment: 32 renal transplant patients
(RTx), 31 maintenance haemodialysis (HD) and 21
chronic peritoneal dialysis (PD) patients; the second
group (II) included terminal breast cancer patients
(n = 25). These patients found themselves relapsing
further into disease and as a result experienced a
significant limitation of their professional and social
activities; the third group (III) comprised healthy
persons (n = 55). The following instruments were
used to conduct the study:
1. State–Trait Anxiety Inventory (STAI) in an
authorized translation by J. Strelau, M. Tys-
karczyk and K. Wrzes´niewski [10]. It is an
adaptation of the American version of the State–
Trate Anxiety Inventory developed by Spielber-
ger et al. [11]. This instrument enables one to
differentiate and to measure independently two
different types of anxiety, namely anxiety under-
stood both as the current state of an individual
(‘‘state anxiety’’) and as a relatively stable trait of
this individual’s personality (‘‘trait anxiety’’).
Both scales contain 20 short statements assessing
the patient’s subjective feelings. The received
results are compared with suitable centile norms.
Results under 30 centile show the low level of
anxiety, between 30 and 60 centiles reflect the
normal level of anxiety and more than 60 centile
indicate the high level of anxiety. This inventory
is an instrument that lives up to the requirements
of modern psychometry. It has high reliability and
accuracy indices, respectively. Estimates of reli-
ability (Cronbach’s alpha) of the Polish version of
the Scale were satisfactory for two scales Anxi-
ety—State (alpha = .90) and Anxiety—Trait
(alpha = .88) [10].
2. Scale of Personal Religiousness (SPR) [12]. This
scale was created by Jaworski. It measures
religious attitudes and enables one to differentiate
between personal religiousness and the apersonal
one. Personal religiousness means deeply rooted
faith in God that is expressed through religious
practices, spiritual development and being a
member of a church community following reli-
gious rules in daily life. Apersonal religiousness is
the opposite of the previous attitude: it reduces
faith to tradition, ceremonies and superficial acts
of worship. The maximum result—210 points—
indicates the personal character of religiousness.
The lowest score—30 points—is the evidence of
apersonal religiousness. There is a continuum of
varied religiousness concerning assessment of
both personal and apersonal attitudes towards
religion. This scale was created in Polish. The
reliability of the scale (Cronbach’s alpha) was
proven of retesting method where satisfactory: for
particular questions (alpha = .69–.86) [12].
3. Rotterdam Symptom Checklist (RSCL) [13]. The
authors of the Polish version of the questionnaire
are Majkowicz and De Walden-Gałuszko [13]. It
is an adaptation of the Scale developed by JCM de
Heas, M. Olschewski and P. Fayers et al. This
checklist assesses the quality of life in cancer
patients throughout self-description. The original
version of the RSCL covers four areas: (a) phys-
ical (somatic) symptoms, (b) psychological prob-
lems, (c) activity level and (d) the overall quality
of life [14]. On the basis of the results and
conclusions drawn from the overall quality of life
study in the general population, five statements
were added regarding the question of social
activity. Estimates of reliability (Cronbach’s
alpha) of the Polish version of this questionnaire
were highly: for physical symptoms scale
(alpha = .86), psychological symptoms scale
(alpha = .83) and activity scale (alpha = .87)
[13].
4. The Mini-Mental Adjustment to Cancer Scale
(Mini-MAC) [16] measuring the following coping
strategies: (a) fighting spirit attitude—facing up to
the challenge and fighting the disease, (b) anxiety
preoccupation—continuous fear and thinking
about the disease, (c) helplessness–hopeless-
ness—feeling resigned to disease, (d) cognitive
avoidance—adopting a new, re-considered
approach to disease and developing a more
appreciative attitude to life as a value itself
(e) fatalism—stoicism, acceptance of disease as
the will Providence.
The author of the Polish version of the Scale is
Z. Juczyn´ski. It is an adaptation of the American
version of the test developed by Watson et al. [15].
The Scale included 29 statements. The results must
be estimated according to each of four strategies
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separately. There are seven statements in each strat-
egy. The range of possible results should be contained
within the limit of 7–28 points. The higher the score
the larger the intensification becomes of the charac-
teristic modes of behaviour for a specified way of
coping with disease. The scores thus obtained should
be converted into standardized units—by means of so-
called stens (i.e. standardized ten-point scales).
Results from 1 to 4 need to be treated as low while
those from 7 to 10 should be regarded as high. Results
in limits 5 and 6 be classified as mean estimates of
reliability (Cronbach’s alpha) of the Polish version of
the Scale were highly: for helplessness–hopelessness
strategy (alpha = .92), fighting spirit attitude (alpha =
.90), anxiety preoccupation strategy (alpha = .89),
cognitive avoidance strategy (alpha = .87), fatalism
(alpha = .64) [16].
5. Medical records served as the source of data with
regard to methods of treatment, comorbidities,
social and demographic details and selected
laboratory indices (Kt/V for dialysis adequacy in
HD and PD patients and eGFR for kidney
allograft function), haematocrit levels.
6. Charlson Comorbidity Index (CCI) [17] was used
as a single aggregate measure of a patient’s
comorbid conditions. CCI scores were calculated
according to age modification as proposed by
Charlson et al. [17].
Statistical methods
Statistical analysis was conducted using the Statistica
9 program. Spearman’s rank correlation coefficient
was used for analysing the correlation level between
variables. The influence of independent variables on
the dependent variables was determined by means of
variance analysis (ANOVA). Differences among sub-
groups were assessed using the Tukey’s test. A p value
\.05 was considered statistically significant. Data are
shown as mean ± standard error.
Results
Basic characteristics of studied groups are presented in
Table 1. Patients with end-stage breast cancer were
women. They displayed no symptoms of comorbidity.
Among patients undergoing RRTs, RTx recipients
were younger than both HD and PD patients; standard
mean ages of dialysis patients were comparable.
Healthy controls were the youngest of all the studied
groups. CCI scores were the lowest for RTX patients
and the highest for HD patients. These findings bore
statistical significance.
Statistical analysis confirmed a significant positive
relationship between trait anxiety and state anxiety.
Analysis of the results showed that patients with
advanced somatic illness (ESRD, breast cancer)
revealed higher levels of anxiety state and trait in
comparison with healthy controls; however, the results
did not reach statistical significance. There was a
tendency towards higher level of anxiety state in breast
cancer patients as compared to ERSD patients under-
going RRT; HD, PD and RTx patients had similar
intensity of anxiety state too. Results are presented in
Table 2.
Tukey’s HSD Post hoc test confirmed no significant
relationship (p [ .05) between level of anxiety and
gender in ESRD patients and healthy control groups.
The coping strategies as helplessness–hopeless-
ness, anxiety preoccupation correlated with level of
anxiety state in ESRD patients undergoing RRT. The
coping strategies as fatalism and anxiety preoccupa-
tion correlated with levels of anxiety state in women
affected by breast cancer.
In contrast to breast cancer patients, in ESRD
patients religiousness had no effect on their anxiety
state. Spearman’s rank correlation coefficient values
for the variables state anxiety, religiousness and
patient ways of coping are presented in Table 3.
QoL was assessed with the help of RSCL. There
were more physical symptoms in breast cancer
patients in comparison with dialysis and renal trans-
plant patients. On the other hand, cancer patients
evaluated higher their overall QoL when compared
with ESRD patients. In RTx patients, general QoL was
significantly better than in HD patients. There was a
difference of borderline significance in the general
QoL evaluation between RTx and PD patients
(p = .054). General QoL did not differ between HD
and PD patients. Psychological symptoms and activity
level did not differ between all groups (cancer and
RRT patients). RTx patients suffered from as many
physical and psychological symptoms as dialysis
patients, yet their self-sufficiency was rated signifi-
cantly higher than in HD patients. In ESRD group,
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there was a significant positive correlation between
physical symptoms, activity level and overall QoL and
CCI scores. RTx recipients with better kidney allograft
function assessed by eGFR experienced fewer phys-
ical symptoms. There was no such interrelationship
with regard to dialysis adequacy assessed by Kt/V in
Table 1 Characteristics of studied group





x ± SD I II III Women Men x ± SD x ± SD x ± SD x ± SD
RTx HD PD N N
I—RRT 53.56 ± 13.94 – .06 .02* 33 51 3.54 ± 1.47 – – –
RTx 44.37 ± 12.87 – .00* .00 – – 13 18 4.45 ± 2.26 4.06 ± 1.18 45.31 ± 12.36 34.4 ± 5.6
HD 59.71 ± 12.22 .00* – .94 – – 9 22 2.34 ± 2.30 6.28 ± 1.68 1.57 ± .15 34.9 ± 4.7
PD 58.48 ± 10.30 .00* .94 – – – 22 10 3.94 ± 3.43 5.67 ± 2.07 2.35 ± .37 35.3 ± 2.5
II—breast
cancer
62.3 ± 12.21 .06 – .00* 25 – 5.5 ± 2.52 – – 36.9 ± .8
III—healthy
controls
44.8 ± 9.23 .02* .00* – 27 28 – – – –
p coefficient of statistical significance
* The marked values are statistically significant, with p \ .05
Table 2 The level of anxiety state and trait in studied groups (data shown in centiles)
Anxiety Group
I—RRT patients II—breast cancer patients III—healthy controls
RTx HD PD Total
State x 51.45 47.53 49.19 49.44 58.20 47.05
SD 10.91 10.85 11.29 10.59 13.26 14.08
Trait x 50.19 51.92 49.39 50.36 49.63 45.68
SD 9.35 9.96 11.13 10.31 9.35 8.32
Table 3 The correlation between anxiety state and coping strategies in studied groups
Variables Group
ESRD patients Breast cancer patients
RTx HD PD Total
r p r p r p r p r p
Religiousness -.18 .33 .14 .45 -.09 .71 -.03 .79 -.74 .000*
Helpless–hopeless .57 .001* .64 .000* .61 .004* .37 .001* .82 .03*
Fatalism -.15 .40 .10 .60 .22 .34 -.09 .40 .79 .000*
Anxious preoccupation .66 .000* .66 .000* .74 .004* .50 .000* .71 .000*
Cognitive avoidance .15 .42 -.048 .83 .18 .46 .048* .71 .81 .04*
Fighting spirit .17 .36 -.10 .59 -.14 .56 -.17 .14 .80 .02*
r the Spearman’s rank correlation coefficient
p coefficient of statistical significance
* The marked values are statistically significant, with p \ .05
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both HD and PD patients (data not shown). The
haematocrit (Hct) levels were measured. These results
did not differ between studied groups.
Table 4 shows the correlation between anxiety state
and various domains of QoL in ESRD and cancer
patients. There was a correlation between level of
anxiety and psychological symptoms and social
activity in RRT patients. In RTx patients, level of
anxiety was also negatively correlated with general
QoL, whereas in HD patients it did not correspond to
the level of social activity. There was no correlation
between somatic symptoms and level of anxiety in any
of ESRD patients, regardless of the mode of RRT. In
contrast to RTx, HD and PD patients, in breast cancer
patients, the intensity of anxiety corresponded to the
results in all domains of RSCL.
There was no significant relationship between level
of anxiety and time of treatment in the studied groups.
Discussion
The findings of the research being presented here have
confirmed that patients with higher levels of trait
anxiety who suffer from advanced somatic disease
reveal more intensive state anxiety. It seems to be
obvious that people with anxiety as a feature of
character will become more anxious when they have to
cope with this disease. We observed that patients with
advanced somatic illness (ESRD, breast cancer)
revealed higher level of anxiety state and trait in
comparison with healthy controls; however, the results
did not reach statistical significance. These results
suggest that anxiety is the frequent emotional reaction
to the chronic somatic disease and can be compared
with the obtained from previous studies conducted on
patients undergoing haemodialysis treatment [18–20].
Anxiety trait is understood as a relatively stable
trait of an individual’s personality. This may suggest
that chronic somatic disease can cause a change of
personality.
Patients with breast cancer revealed higher levels of
anxiety than other studied patients including ESRD
patients. In a study by Majkowicz et al. [21], cancer
patients expressed significantly higher levels of
depression and anxiety while HD patients manifested
higher levels of aggression. Moreover, it is typical of
end-stage cancer to make existing symptoms become
periodically aggravated and cause new ones to appear.
New symptoms will tend to arouse anxiety [22]. The
fact that cancer patients were all women could be
important for the level of anxiety. Some researchers
point to gender dimension as one of the factors
influencing on anxiety level [23, 24]. A study carried
out by Spencer et al. [25] showed that female patients,
more physically impaired and younger advanced
cancer patients are more likely to meet criteria for an
anxiety disorder.
As expected, terminal cancer patients rated their
somatic condition worst of all study groups. It is
surprising that cancer patients scored overall QoL
better when compared to dialysis and renal transplant
patients. The possible explanation is that renal patients
tend to be affected by medical therapy more heavily.
Table 4 The correlation between physical symptoms, psychological symptoms, social activity and general QoL and level of anxiety
in ESRD and cancer patients
Scale of RSCL Group
RRT patients Breast cancer patients
RTx HD PD Total r p
r p r p r p r p
Physical symptoms .30 .10 .00* .96 .32 .16 .15 .17 .44 .02*
Psychological symptoms .66 .00* .57 .00* .61 .00* .38 .00* .69 .00*
Activity level .55 .00* .08 .67 .46 .04* .30* .00* .19 .01*
General QoL .54 .00* .08 .67 .19 .44 .21 .06 .74 .03*
r the Spearman’s rank correlation coefficient
p coefficient of statistical significance
* The marked values are statistically significant, with p \ .05
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In many countries, this is the reason for the withdrawal
of aggressive treatment for dialysis patients [26].
Renal transplantation is the ideal choice of treat-
ment for ESRD. Not only does it improve one’s
chances of survival, but it is believed to be the least
stressful of RRTs since it brings patients fewer life
style restrictions and improves their physical and
psycho-social well-being. Therefore, successful trans-
plantation should mitigate high level of negative
emotions observed in dialysis patients. Among studies
comparing the condition of mental health between
haemoperitoneal dialysis and transplant patients, some
have shown an improvement in anxiety after renal
transplantation [27, 28], while others have revealed no
sign of superiority of any of the RRT modes [29].
In our study, HD, PD and RTx patients had similar
intensity of anxiety state, while their general evalua-
tion of QoL differed with RTx recipients experiencing
best QoL. This was surprising as RTx patients were
younger and manifested fewer instances of comorbid-
ity than dialysis patients. We would have expected
these patients to express lower levels of negative
emotions than HD or PD patients. Our findings are
especially surprising as most of the previous studies
showed a favourable effect of renal transplantation on
the improvement in anxiety state [27, 28]. We would
well have expected PD patients to have a better QoL
than their HD counterparts, even comparable to
healthy individuals, for example, because this method
of RRT allows increased autonomy [20, 21]. On the
other hand, in a study by Sayin et al. [29], QoL was
similar to that of HD, PD and RTx patients. However,
anxiety levels influenced QoL in the case of HD and
PD patients alone—RTx recipients remained unaf-
fected. This is consistent with our observation that
while all patients undergoing RRTs maintained sim-
ilar anxiety state levels, RTx patients scored best
overall QoL. We can thus hypothesize that RTx
patients, who have the highest functional capacity and
QoL, become anxious about a possible loss of these
values. Although RTx patients suffered from as many
physical and psychological symptoms as dialysis
patients did, their self-sufficiency, constituting a
highly appreciated quality, was enough to boost their
QoL.
Intrinsic religiousness was the most effective factor
diminishing anxiety in advanced breast cancer patients
as opposed to dialysis and transplant ones. Women
with intrinsic religiousness show the lower intensity of
anxiety; on the other hand, patients with extrinsic
religiousness display a higher level of anxiety. Some
researchers point to the transcendental dimension as
one of the mechanisms for coping with the fear of
death [30–33]. Alvarado et al. [34] showed that people
with low levels of the fear of death strongly believe in
afterlife. Moreover, a study by Phelps et al. [35]
showed that religious coping in advanced cancer
patients is associated with receipt of intensive life-
prolonging medical care near death defined as receipt
of mechanical ventilation or cardiopulmonary resus-
citation in the last week of life.
The analysis of ways of coping with disease
revealed that the strategies as helplessness–hopeless-
ness, anxiety preoccupation correlated with level of
anxiety state in patients with ESRD undergoing RRT
and the strategies as fatalism and anxiety preoccupa-
tion correlated with level of anxiety state in women
with breast cancer. The coping strategies were
assigned to either of two categories: constructive
coping strategies (fighting spirit, cognitive avoidance)
and non-constructive coping strategies (helpless–
hopeless, anxious preoccupation, fatalism). We
observed that non-constructive ways of coping corre-
lated with higher level of anxiety in studied groups.
Our study on 155 women with breast cancer at
different disease stages has shown that patients
preferring constructive coping strategies revealed
lower levels of anxiety when compared to patients
manifesting non-constructive forms of coping [36].
Our results concerning patients who receive RRTs are
consistent with the report of Takaki et al. [37], who
have shown that emotion-oriented coping such as
anxiety preoccupation correlated positively with level
of anxiety in over 400 HD patients.
In ESRD patients’ correlation between level of
anxiety and general quality of life, psychological state
and social activity depended on mode of treatment.
There was no correlation between somatic symptoms
and levels of anxiety in the case of dialysis and renal
transplant patients. The breast cancer patients’ inten-
sity of anxiety correlated with the results in all
domains of RSCL. In the phase of recurring cancer,
the somatic condition has the most significant influ-
ence on the levels of state anxiety. Somatic signs at
this stage of the disease worsen patients’ health
condition and bring about their feeling of threat.
Study limitations include the potential for self-
report response bias and sampling bias because of
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convenience sampling. We also decided to use tools
originally designed for cancer patients that so far have
not been verified with ESRD patients. However, this
was the only possible way to make comparisons
between patients suffering from advanced stages of
renal diseases and cancer.
In addition, we cannot exclude the idea that a
tendency towards higher levels of anxiety state among
cancer—affected patients may be associated with their
gender. Despite these limitations, we believe that our
study is of significant importance as to our knowledge
this is the first study to compare anxiety and coping
strategies along with religiousness in patients under-
going three different treatment strategies in ESRD.
Moreover, our findings thus obtained are further
juxtaposed with those from research done into healthy
individuals, on the one hand, and cancer patients on
the other.
Conclusions
Patients with a high level of trait anxiety show higher
intensity of state anxiety during advanced somatic
disease. ESRD patients undergoing RRT present
higher level of anxiety than healthy controls and
lower than breast cancer patients. The intensity of
anxiety is similar irrespectively of the mode of renal
replacement therapy (RTx, HD and PD). An elevated
level of anxiety trait in patients with advanced disease
suggests that the presence of chronic somatic illness
modifies this personality feature. The phenomenon of
intrinsic religiousness works as a factor most effi-
ciently diminishing the levels of anxiety in advanced
breast cancer patients as opposed to dialysis and
transplant patients. In patients with advanced somatic
disease (ESRD patients and women with breast
cancer), non-constructive strategies of coping with
the disease require further evaluation and possibly
more psychological support.
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